{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T04:03:10Z","timestamp":1748491390173,"version":"3.41.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"DOI":"10.1186\/s12905-025-03772-6","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T08:55:45Z","timestamp":1748422545000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of risk factors for high-grade cervical or endometrial lesions to triage women with AGC-FN: a retrospective study"],"prefix":"10.1186","volume":"25","author":[{"given":"Shuxia","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangzhi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xite","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binhua","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"key":"3772_CR1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3109\/07357907.2014.880453","volume":"32","author":"T Shoji","year":"2014","unstructured":"Shoji T, Takatori E, Takeuchi S, Yoshizaki A, Uesugi N, Sugai T, et al. Clinical significance of atypical glandular cells in the Bethesda system 2001: a comparison with the histopathological diagnosis of surgically resected specimens. Cancer Invest. 2014;32:105\u20139.","journal-title":"Cancer Invest"},{"key":"3772_CR2","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1002\/dc.23777","volume":"45","author":"MK Kim","year":"2017","unstructured":"Kim MK, Lee YK, Hong SR, Lim KT. Clinicopathological significance of atypical glandular cells on cervicovaginal Pap smears. Diagn Cytopathol. 2017;45:867\u201372.","journal-title":"Diagn Cytopathol"},{"key":"3772_CR3","first-page":"266","volume":"47","author":"MM Hammoud","year":"2002","unstructured":"Hammoud MM, Haefner HK, Michael CW, Ansbacher R. Atypical glandular cells of undetermined significance Histologic findings and proposed management. J Reprod Med. 2002;47:266\u201370.","journal-title":"J Reprod Med"},{"key":"3772_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4103\/JOC.JOC_209_16","volume":"34","author":"G Boyraz","year":"2017","unstructured":"Boyraz G, Basaran D, Salman MC, Ibrahimov A, Onder S, Akman O, et al. Histological follow-up in patients with atypical glandular cells on pap smears. J Cytol. 2017;34:203\u20137.","journal-title":"J Cytol"},{"key":"3772_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.25259\/Cytojournal_77_2019","volume":"17","author":"P Zhong","year":"2020","unstructured":"Zhong P, Yin C, Jin Y, Chen T, Zhan Y, Tian C, et al. More focus on atypical glandular cells in cervical screening: Risk of significant abnormalities and low histological follow-up rate. Cytojournal. 2020;17:22.","journal-title":"Cytojournal"},{"key":"3772_CR6","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.2147\/TCRM.S179334","volume":"14","author":"X Mao","year":"2018","unstructured":"Mao X, Ruan G, Dong B, Chen L, Xu S, Lin F, et al. Clinical validation of the Cervista(\u00ae) high-risk human papillomavirus test in Chinese women from Fujian province: a cross-sectional study. Ther Clin Risk Manag. 2018;14:2243\u201353.","journal-title":"Ther Clin Risk Manag"},{"key":"3772_CR7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","volume":"24","author":"RB Perkins","year":"2020","unstructured":"Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, et al. 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis. 2020;24:102\u201331.","journal-title":"J Low Genit Tract Dis"},{"key":"3772_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/cncy.21521","volume":"123","author":"R Nayar","year":"2015","unstructured":"Nayar R, Wilbur DC. The Pap test and Bethesda 2014. Cancer Cytopathol. 2015;123:271\u201381.","journal-title":"Cancer Cytopathol"},{"key":"3772_CR9","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.tjog.2020.07.007","volume":"59","author":"M Kengsakul","year":"2020","unstructured":"Kengsakul M, Manchana T. Coexisting cancers with atypical glandular abnormalities by liquid-based cytology: a retrospective study in tertiary hospital in a high cervical cancer incident country. Taiwan J Obstet Gynecol. 2020;59:665\u20138.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"3772_CR10","doi-asserted-by":"publisher","first-page":"210","DOI":"10.4103\/JOC.JOC_54_21","volume":"38","author":"E Keles","year":"2021","unstructured":"Keles E, Ozturk UK, Al\u0131nca CM, Giray B, Kabaca C, Cetiner H. Factors affecting the histopathological outcomes of atypical glandular cells on pap test. J Cytol. 2021;38:210\u20135.","journal-title":"J Cytol"},{"key":"3772_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1080\/07357907.2018.1547738","volume":"37","author":"TK Jang","year":"2019","unstructured":"Jang TK, Park JY, Kim DY, Suh DS, Kim JH, Kim YM, et al. Histologic correlation and clinical significance of atypical glandular cells on cervical pap tests: analysis of 540 cases at a single institution. Cancer Invest. 2019;37:8\u201315.","journal-title":"Cancer Invest"},{"key":"3772_CR12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1159\/000498977","volume":"63","author":"S Toyoda","year":"2019","unstructured":"Toyoda S, Kawaguchi R, Kobayashi H. Clinicopathological characteristics of atypical glandular cells determined by cervical cytology in Japan: survey of gynecologic oncology data from the obstetrical gynecological society of Kinki District. Japan Acta Cytol. 2019;63:361\u201370.","journal-title":"Japan Acta Cytol"},{"key":"3772_CR13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/cncy.21791","volume":"125","author":"S Patadji","year":"2017","unstructured":"Patadji S, Li Z, Pradhan D, Zhao C. Significance of high-risk HPV detection in women with atypical glandular cells on pap testing: analysis of 1857 cases from an academic institution. Cancer Cytopathol. 2017;125:205\u201311.","journal-title":"Cancer Cytopathol"},{"key":"3772_CR14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/AOG.0b013e3181c799a3","volume":"115","author":"PE Castle","year":"2010","unstructured":"Castle PE, Fetterman B, Poitras N, Lorey T, Shaber R, Kinney W. Relationship of atypical glandular cell cytology, age, and human papillomavirus detection to cervical and endometrial cancer risks. Obstet Gynecol. 2010;115:243\u20138.","journal-title":"Obstet Gynecol"},{"key":"3772_CR15","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.3802\/jgo.2019.30.e29","volume":"30","author":"Y Kang","year":"2019","unstructured":"Kang Y, Sun P, Mao X, Dong B, Ruan G, Chen L. PCR-reverse dot blot human papillomavirus genotyping as a primary screening test for cervical cancer in a hospital-based cohort. J Gynecol Oncol. 2019;30:e29.","journal-title":"J Gynecol Oncol"},{"key":"3772_CR16","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.2147\/CMAR.S179724","volume":"10","author":"B Dong","year":"2018","unstructured":"Dong B, Sun P, Ruan G, Huang W, Mao X, Kang Y, et al. Type-specific high-risk human papillomavirus viral load as a viable triage indicator for high-grade squamous intraepithelial lesion: a nested case- control study. Cancer Manag Res. 2018;10:4839\u201351.","journal-title":"Cancer Manag Res"},{"key":"3772_CR17","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jmoldx.2010.11.016","volume":"13","author":"KE Youens","year":"2011","unstructured":"Youens KE, Hosler GA, Washington PJ, Jenevein EP, Murphy KM. Clinical experience with the Cervista HPV HR assay: correlation of cytology and HPV status from 56,501 specimens. J Mol Diagn. 2011;13:160\u20136.","journal-title":"J Mol Diagn"},{"key":"3772_CR18","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.3802\/jgo.2017.28.e50","volume":"28","author":"P Sun","year":"2017","unstructured":"Sun P, Song Y, Ruan G, Mao X, Kang Y, Dong B, et al. Clinical validation of the PCR-reverse dot blot human papillomavirus genotyping test in cervical lesions from Chinese women in the Fujian province: a hospital-based population study. J Gynecol Oncol. 2017;28:e50.","journal-title":"J Gynecol Oncol"},{"issue":"Suppl 3","key":"3772_CR19","doi-asserted-by":"publisher","first-page":"S340","DOI":"10.1590\/S0036-36342003000900007","volume":"45","author":"C Bergeron","year":"2003","unstructured":"Bergeron C. The 2001 Bethesda system. Salud Publica Mex. 2003;45(Suppl 3):S340\u20134.","journal-title":"Salud Publica Mex"},{"key":"3772_CR20","doi-asserted-by":"publisher","first-page":"4332","DOI":"10.7150\/jca.55826","volume":"12","author":"H Xue","year":"2021","unstructured":"Xue H, Gao H, Zheng J, Chen Y, Chen J, Pan D, et al. Use of extended HR-HPV genotyping in improving the triage strategy of 2019 ASCCP recommendations in Women with positive HR-HPV diagnosis and Simultaneous LSIL Cytology Results. J Cancer. 2021;12:4332\u201340.","journal-title":"J Cancer"},{"key":"3772_CR21","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.3390\/diagnostics11081420","volume":"11","author":"M Trzeszcz","year":"2021","unstructured":"Trzeszcz M, Mazurec M, Jach R, Mazurec K, Jach Z, Kotkowska-Szeps I, et al. Liquid-based screening tests results: HPV, liquid-based cytology, and P16\/Ki67 dual-staining in private-based opportunistic cervical cancer screening. Diagnostics (Basel). 2021;11:1420.","journal-title":"Diagnostics (Basel)."},{"key":"3772_CR22","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1002\/dc.24891","volume":"49","author":"Q Luo","year":"2021","unstructured":"Luo Q, Lang L, Han N, Liang L, Shen L, Zhang H. Prevalence and genotype distribution of high-risk human papillomavirus infection among women with cervical cytological abnormalities in Chongqing, China, 2014\u20132020. Diagn Cytopathol. 2021;49:1237\u201343.","journal-title":"Diagn Cytopathol"},{"key":"3772_CR23","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ygyno.2017.07.130","volume":"147","author":"T Knific","year":"2017","unstructured":"Knific T, Osredkar J, Smrkolj \u0160, Tonin I, Vouk K, Blejec A, et al. Novel algorithm including CA-125, HE4 and body mass index in the diagnosis of endometrial cancer. Gynecol Oncol. 2017;147:126\u201332.","journal-title":"Gynecol Oncol"},{"key":"3772_CR24","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/ijc.29424","volume":"138","author":"F Verdoodt","year":"2016","unstructured":"Verdoodt F, Jiang X, Williams M, Schnatz PF, Arbyn M. High-risk HPV testing in the management of atypical glandular cells: a systematic review and meta-analysis. Int J Cancer. 2016;138:303\u201310.","journal-title":"Int J Cancer"},{"key":"3772_CR25","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.ygyno.2009.05.019","volume":"114","author":"C Zhao","year":"2009","unstructured":"Zhao C, Florea A, Onisko A, Austin RM. Histologic follow-up results in 662 patients with Pap test findings of atypical glandular cells: results from a large academic womens hospital laboratory employing sensitive screening methods. Gynecol Oncol. 2009;114:383\u20139.","journal-title":"Gynecol Oncol"},{"key":"3772_CR26","first-page":"913","volume":"35","author":"KC Asciutto","year":"2015","unstructured":"Asciutto KC, Henic E, Forslund O, Bjelkenkrantz K, Borgfeldt C. Age influences the clinical significance of atypical glandular cells on cytology. Anticancer Res. 2015;35:913\u20139.","journal-title":"Anticancer Res"},{"key":"3772_CR27","doi-asserted-by":"publisher","first-page":"270","DOI":"10.15537\/smj.2021.42.3.20200814","volume":"42","author":"S Husain","year":"2021","unstructured":"Husain S, Al Hammad RS, Alduhaysh AK, AlBatly MM, Alrikabi A. Pathological spectrum of endometrial biopsies in Saudi women with abnormal uterine bleeding: A retrospective study of 13-years. Saudi Med J. 2021;42:270\u20139.","journal-title":"Saudi Med J"},{"key":"3772_CR28","doi-asserted-by":"publisher","first-page":"e268","DOI":"10.1016\/S1470-2045(13)70591-6","volume":"15","author":"R Murali","year":"2014","unstructured":"Murali R, Soslow RA, Weigelt B. Classification of endometrial carcinoma: more than two types. Lancet Oncol. 2014;15:e268\u201378.","journal-title":"Lancet Oncol"},{"key":"3772_CR29","doi-asserted-by":"publisher","first-page":"Cr618","DOI":"10.12659\/MSM.882046","volume":"17","author":"SM He","year":"2011","unstructured":"He SM, Xing F, Sui H, Wu Y, Wang Y, Wang D, et al. Determination of CA-125 levels in the serum, cervical and vaginal secretions, and endometrium in Chinese women with precancerous disease or endometrial cancer. Med Sci Monit. 2011;17:Cr618\u201325.","journal-title":"Med Sci Monit"},{"key":"3772_CR30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.biopha.2003.11.003","volume":"58","author":"A Gadducci","year":"2004","unstructured":"Gadducci A, Cosio S, Carpi A, Nicolini A, Genazzani AR. Serum tumor markers in the management of ovarian, endometrial and cervical cancer. Biomed Pharmacother. 2004;58:24\u201338.","journal-title":"Biomed Pharmacother"},{"key":"3772_CR31","doi-asserted-by":"publisher","first-page":"884","DOI":"10.3892\/ol.2020.11634","volume":"20","author":"C Han","year":"2020","unstructured":"Han C, Zhao F, Wan C, He Y, Chen Y. Associations between the expression of SCCA, MTA1, P16, Ki-67 and the infection of high-risk HPV in cervical lesions. Oncol Lett. 2020;20:884\u201392.","journal-title":"Oncol Lett"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-03772-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-025-03772-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-03772-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T08:55:45Z","timestamp":1748422545000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-025-03772-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3772"],"URL":"https:\/\/doi.org\/10.1186\/s12905-025-03772-6","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"6 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical clearance to conduct the study was obtained from the Ethics Committees of the Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University (no. 2019\u2013033). Informed consent was waived by the Ethics Committee of the Fujian Maternity and Child Health Hospital since all clinical data were extracted from the medical system and personal information of the patients was anonymized. Personal and medication information of the patients were recorded while maintaining patient confidentiality and blinding their names and addresses. This study was performed in accordance with the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"260"}}